Korea United Pharm Inc
KRX:033270

Watchlist Manager
Korea United Pharm Inc Logo
Korea United Pharm Inc
KRX:033270
Watchlist
Price: 20 850 KRW
Market Cap: 306.7B KRW
Have any thoughts about
Korea United Pharm Inc?
Write Note

Intrinsic Value

The intrinsic value of one Korea United Pharm Inc stock under the Base Case scenario is 43 960.93 KRW. Compared to the current market price of 20 850 KRW, Korea United Pharm Inc is Undervalued by 53%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
43 960.93 KRW
Undervaluation 53%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Korea United Pharm Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Korea United Pharm Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Korea United Pharm Inc?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Pharmaceuticals Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Korea United Pharm Inc

Provide an overview of the primary business activities
of Korea United Pharm Inc.

What unique competitive advantages
does Korea United Pharm Inc hold over its rivals?

What risks and challenges
does Korea United Pharm Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Korea United Pharm Inc.

Provide P/S
for Korea United Pharm Inc.

Provide P/E
for Korea United Pharm Inc.

Provide P/OCF
for Korea United Pharm Inc.

Provide P/FCFE
for Korea United Pharm Inc.

Provide P/B
for Korea United Pharm Inc.

Provide EV/S
for Korea United Pharm Inc.

Provide EV/GP
for Korea United Pharm Inc.

Provide EV/EBITDA
for Korea United Pharm Inc.

Provide EV/EBIT
for Korea United Pharm Inc.

Provide EV/OCF
for Korea United Pharm Inc.

Provide EV/FCFF
for Korea United Pharm Inc.

Provide EV/IC
for Korea United Pharm Inc.

Show me price targets
for Korea United Pharm Inc made by professional analysts.

What are the Revenue projections
for Korea United Pharm Inc?

How accurate were the past Revenue estimates
for Korea United Pharm Inc?

What are the Net Income projections
for Korea United Pharm Inc?

How accurate were the past Net Income estimates
for Korea United Pharm Inc?

What are the EPS projections
for Korea United Pharm Inc?

How accurate were the past EPS estimates
for Korea United Pharm Inc?

What are the EBIT projections
for Korea United Pharm Inc?

How accurate were the past EBIT estimates
for Korea United Pharm Inc?

Compare the revenue forecasts
for Korea United Pharm Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Korea United Pharm Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Korea United Pharm Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Korea United Pharm Inc compared to its peers.

Compare the P/E ratios
of Korea United Pharm Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Korea United Pharm Inc with its peers.

Analyze the financial leverage
of Korea United Pharm Inc compared to its main competitors.

Show all profitability ratios
for Korea United Pharm Inc.

Provide ROE
for Korea United Pharm Inc.

Provide ROA
for Korea United Pharm Inc.

Provide ROIC
for Korea United Pharm Inc.

Provide ROCE
for Korea United Pharm Inc.

Provide Gross Margin
for Korea United Pharm Inc.

Provide Operating Margin
for Korea United Pharm Inc.

Provide Net Margin
for Korea United Pharm Inc.

Provide FCF Margin
for Korea United Pharm Inc.

Show all solvency ratios
for Korea United Pharm Inc.

Provide D/E Ratio
for Korea United Pharm Inc.

Provide D/A Ratio
for Korea United Pharm Inc.

Provide Interest Coverage Ratio
for Korea United Pharm Inc.

Provide Altman Z-Score Ratio
for Korea United Pharm Inc.

Provide Quick Ratio
for Korea United Pharm Inc.

Provide Current Ratio
for Korea United Pharm Inc.

Provide Cash Ratio
for Korea United Pharm Inc.

What is the historical Revenue growth
over the last 5 years for Korea United Pharm Inc?

What is the historical Net Income growth
over the last 5 years for Korea United Pharm Inc?

What is the current Free Cash Flow
of Korea United Pharm Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Korea United Pharm Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Korea United Pharm Inc

Current Assets 245.1B
Cash & Short-Term Investments 133.8B
Receivables 49.3B
Other Current Assets 62.1B
Non-Current Assets 240.9B
Long-Term Investments 74.2B
PP&E 151B
Intangibles 9.2B
Other Non-Current Assets 6.5B
Current Liabilities 79.8B
Accounts Payable 16.6B
Accrued Liabilities 18.1B
Other Current Liabilities 45B
Non-Current Liabilities 19.6B
Long-Term Debt 14.7B
Other Non-Current Liabilities 4.9B
Efficiency

Earnings Waterfall
Korea United Pharm Inc

Revenue
285.8B KRW
Cost of Revenue
-122.7B KRW
Gross Profit
163.1B KRW
Operating Expenses
-107.3B KRW
Operating Income
55.8B KRW
Other Expenses
-23.6B KRW
Net Income
32.2B KRW

Free Cash Flow Analysis
Korea United Pharm Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Korea United Pharm Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive 3-Years Revenue Growth
59/100
Profitability
Score

Korea United Pharm Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Korea United Pharm Inc's solvency score is 94/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Long-Term Solvency
Negative Net Debt
High Altman Z-Score
94/100
Solvency
Score

Korea United Pharm Inc's solvency score is 94/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Korea United Pharm Inc

Wall Street analysts forecast Korea United Pharm Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Korea United Pharm Inc is 37 740 KRW with a low forecast of 37 370 KRW and a high forecast of 38 850 KRW.

Lowest
Price Target
37 370 KRW
79% Upside
Average
Price Target
37 740 KRW
81% Upside
Highest
Price Target
38 850 KRW
86% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Korea United Pharm Inc?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Korea United Pharm Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Korea United Pharm Inc Logo
Korea United Pharm Inc

Country

Korea

Industry

Pharmaceuticals

Market Cap

306.7B KRW

Dividend Yield

2.01%

Description

KOREA UNITED PHARM, Inc. engages in the manufacture and distribution of pharmaceuticals and healthcare products. The company is headquartered in Sejong, Sejong and currently employs 885 full-time employees. The company went IPO on 2007-10-23. INC. is a Korea-based company engaged in the manufacture and marketing of pharmaceuticals. The Company’s products include remedies for gastrointestinal system, cardiovascular, hematopoietic system, respiratory system, central nervous system, musculoskeletal system, endocrine and metabolic system, allergy and immune system, as well as anti-infectives, gynecological agents, vitamins, nutrition products, anticancer medicines and others. The company also provides active pharmaceutical ingredients (APIs) and various health food products. The firm distributes its products within domestic market and to overseas markets.

Contact

SEJONG
Sejong
25-23, Nojanggongdan-gil, Jeondong-myeon
+82448625030
www.kup.co.kr

IPO

2007-10-23

Employees

885

Officers

See Also

Discover More
What is the Intrinsic Value of one Korea United Pharm Inc stock?

The intrinsic value of one Korea United Pharm Inc stock under the Base Case scenario is 43 960.93 KRW.

Is Korea United Pharm Inc stock undervalued or overvalued?

Compared to the current market price of 20 850 KRW, Korea United Pharm Inc is Undervalued by 53%.

Back to Top